IndraLab

Statements

USP18 inhibits SARS-CoV-2. 1 / 1

| 1

reach

"Therefore, these results suggested that inhibiting the expression of IFIT3, OASL, USP18, XAF1, IFI27, and EPSTI1 may reduce the risk of SARS-CoV-2 infection and may also have a positive effect on antiviral therapy in patients with SARS-CoV-2 infection.and 4G)."

34009691

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP18 inhibits SARS-CoV-2. 1 / 1

INDRA sources:

Databases

Reading